KR20130105659A - 광범위 스펙트럼 항생제 아릴로마이신 유사체 - Google Patents

광범위 스펙트럼 항생제 아릴로마이신 유사체 Download PDF

Info

Publication number
KR20130105659A
KR20130105659A KR1020137009510A KR20137009510A KR20130105659A KR 20130105659 A KR20130105659 A KR 20130105659A KR 1020137009510 A KR1020137009510 A KR 1020137009510A KR 20137009510 A KR20137009510 A KR 20137009510A KR 20130105659 A KR20130105659 A KR 20130105659A
Authority
KR
South Korea
Prior art keywords
alkyl
staphylococcus
aryl
arylomycin
groups
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020137009510A
Other languages
English (en)
Korean (ko)
Inventor
플로이드 이 로멤스버그
피터 에이 스미스
터커 씨 로버츠
Original Assignee
더 스크립스 리서치 인스티튜트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 더 스크립스 리서치 인스티튜트 filed Critical 더 스크립스 리서치 인스티튜트
Publication of KR20130105659A publication Critical patent/KR20130105659A/ko
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
KR1020137009510A 2010-09-15 2011-08-31 광범위 스펙트럼 항생제 아릴로마이신 유사체 Withdrawn KR20130105659A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38298810P 2010-09-15 2010-09-15
US61/382,988 2010-09-15
PCT/US2011/049967 WO2012036907A2 (en) 2010-09-15 2011-08-31 Broad spectrum antibiotic arylomycin analogs

Publications (1)

Publication Number Publication Date
KR20130105659A true KR20130105659A (ko) 2013-09-25

Family

ID=45832167

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020137009510A Withdrawn KR20130105659A (ko) 2010-09-15 2011-08-31 광범위 스펙트럼 항생제 아릴로마이신 유사체

Country Status (10)

Country Link
US (1) US9187524B2 (cg-RX-API-DMAC7.html)
EP (1) EP2616093A4 (cg-RX-API-DMAC7.html)
JP (1) JP2013539751A (cg-RX-API-DMAC7.html)
KR (1) KR20130105659A (cg-RX-API-DMAC7.html)
CN (1) CN103209700A (cg-RX-API-DMAC7.html)
BR (1) BR112013006265A2 (cg-RX-API-DMAC7.html)
CA (1) CA2811295A1 (cg-RX-API-DMAC7.html)
MX (1) MX2013003035A (cg-RX-API-DMAC7.html)
RU (1) RU2013112483A (cg-RX-API-DMAC7.html)
WO (1) WO2012036907A2 (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2013003035A (es) 2010-09-15 2013-12-16 Scripps Research Inst Analogos de arilomicina como antibióticos de amplio espectro.
WO2012166665A2 (en) * 2011-05-27 2012-12-06 Rqx Pharmaceuticals, Inc. Broad spectrum antibiotics
US10501493B2 (en) 2011-05-27 2019-12-10 Rqx Pharmaceuticals, Inc. Broad spectrum antibiotics
KR20140140580A (ko) * 2012-03-14 2014-12-09 더 스크립스 리서치 인스티튜트 광범위 항생제 아릴로마이신 유사체
CA2892027A1 (en) * 2012-11-21 2014-05-30 Rqx Pharmaceuticals, Inc. Macrocyclic broad spectrum antibiotics
CN103103261A (zh) * 2013-01-05 2013-05-15 张国新 检测幽门螺杆菌对克拉霉素耐药性试剂盒及制备方法
KR20170027721A (ko) * 2014-05-20 2017-03-10 알큐엑스 파마슈티컬스, 인크. 마크로시클릭 광범위 항생제
CN107106533B (zh) * 2014-10-31 2020-11-06 罗切斯特大学 用于治疗微生物感染的增效组合物
KR20180109858A (ko) 2015-11-20 2018-10-08 알큐엑스 파마슈티컬스, 인크. 마크로시클릭 광범위 항생제
WO2017214534A1 (en) 2016-06-10 2017-12-14 The Scripps Research Institute Synthesis of the arylomycin macrocyclic core
UA126027C2 (uk) * 2017-02-15 2022-08-03 АрКьюЕкс ФАРМАСЬЮТІКЛС, ІНК. Макроциклічні антибіотики широкого спектра
EP3388445A1 (en) * 2017-04-10 2018-10-17 F. Hoffmann-La Roche AG Peptide macrocycles and use thereof in the treatment of bacterial infections
IL288294B (en) 2019-05-28 2022-09-01 Hoffmann La Roche A broad-spectrum macrocyclic antibiotic
CN116023430B (zh) * 2022-12-20 2025-11-25 中国药科大学 2-(2-(2-苯甲酰氨基)乙酰胺)苯甲酸类衍生物及其制备方法和用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11514527A (ja) 1995-11-03 1999-12-14 イー・アイ・デユポン・ドウ・ヌムール・アンド・カンパニー バキルス エスピー(Bacillus sp.)用の陽性選択ベクター
US6951840B2 (en) * 2001-08-31 2005-10-04 Eli Lilly And Company Lipoglycopeptide antibiotics
DE102005014245A1 (de) 2005-03-30 2006-10-05 Aicuris Gmbh & Co. Kg Antibakterielle Amid-Makrozyklen V
CN102939095A (zh) * 2010-03-09 2013-02-20 默沙东公司 增强β-内酰胺抗菌药物的活性的桥联脂糖肽类
MX2013003035A (es) 2010-09-15 2013-12-16 Scripps Research Inst Analogos de arilomicina como antibióticos de amplio espectro.
WO2012166665A2 (en) 2011-05-27 2012-12-06 Rqx Pharmaceuticals, Inc. Broad spectrum antibiotics
KR20140140580A (ko) 2012-03-14 2014-12-09 더 스크립스 리서치 인스티튜트 광범위 항생제 아릴로마이신 유사체

Also Published As

Publication number Publication date
MX2013003035A (es) 2013-12-16
BR112013006265A2 (pt) 2016-06-07
RU2013112483A (ru) 2014-10-20
WO2012036907A3 (en) 2012-08-09
US20130281360A1 (en) 2013-10-24
EP2616093A4 (en) 2014-02-26
EP2616093A2 (en) 2013-07-24
WO2012036907A2 (en) 2012-03-22
US9187524B2 (en) 2015-11-17
CA2811295A1 (en) 2012-03-22
JP2013539751A (ja) 2013-10-28
CN103209700A (zh) 2013-07-17

Similar Documents

Publication Publication Date Title
US9187524B2 (en) Broad spectrum antibiotic arylomycin analogs
US20160297851A1 (en) Broad spectrum antibiotic arylomycin analogs
Bhandari et al. The role of ClpP protease in bacterial pathogenesis and human diseases
AU2024201593B2 (en) A genetically modified Lactobacillus and uses thereof
McBrayer et al. Development and utilization of peptide-based quorum sensing modulators in Gram-positive bacteria
TWI642684B (zh) 廣效性抗生素
TWI631127B (zh) 巨環廣效抗生素
US9708368B2 (en) Linear peptide antibiotics
Roberts et al. Initial efforts toward the optimization of arylomycins for antibiotic activity
ES2296694T3 (es) Diana de la proteina de activacion de arniii (trap).
Bikash et al. Structure activity relationship study of the XIP quorum sensing pheromone in Streptococcus mutans reveal inhibitors of the competence regulon
CN111386283A (zh) 肽抗菌复合物及其使用方法
US10501493B2 (en) Broad spectrum antibiotics
Tiwari et al. Targeting Pili‐Mediated Interactions to Control Dental Plaque Formation
WO2004018507A1 (en) Compositions and methods for treatment and prophylaxis of infections caused by gram positive bacteria
AU777774B2 (en) Novel method for identifying antibacterial compounds
Chiorean Investigating Structural Properties of Antibacterial Peptides
BR112014020375A2 (pt) Compostos lipopeptídicos, sua composição farmacêutica e seu uso
JPH11253178A (ja) Abc輸送体

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20130415

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid